Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis
Эффективность фармакологических препаратов в снижении обструкции выносящего тракта у пациентов с обструктивной гипертрофической кардиомиопатией: систематический обзор и мета-анализ
2025-05-16
SCID: 54.1/htfqebwj
Discuss with AI
beta-blockerscalcium channel blockerscardiac myosin inhibitorsdisopyramideleft ventricular outflow tract gradientmeta-analysisobstructive hypertrophic cardiomyopathysystematic review
Figures from the paper
Abstract (AI)
AIMS: Significant advancements have been made in the management of obstructive hypertrophic cardiomyopathy (oHCM), yet the extent of left ventricular outflow tract (LVOT) gradient reduction achieved with commonly used pharmacological therapies [beta-blockers (BBs), calcium channel blockers (CCBs), disopyramide, and cardiac myosin inhibitors (CMIs)] relative to each other is still unclear. METHODS AND RESULTS: PubMed and Scopus were searched up to September 2024. Clinical trials or observational studies that assessed the changes associated with BBs, CCBs, disopyramide, or CMIs in LVOT gradient at rest or with provocation in patients with oHCM were included. Mean changes in LVOT gradients were pooled as mean differences (MD) with 95% confidence intervals (CIs) in a random-effects model. Thirty-seven studies, with 44 arms and 1898 patients, were included in the analysis. At the therapeutic class level, pooled analysis showed that disopyramide was associated with the highest reduction in LVOT gradient at rest [MD: -43.5 (95% CI, -51.6 to -35.3)], followed by CMIs [MD: -34.8 (95% CI, -40.6 to -29.0)], BBs [MD: -20.7 (95% CI, -29.4 to -12.0)], and then CCBs [MD: -14.7 (95% CI, -23.3 to -6.1)], inter-action P < 0.01. Within CMIs, mavacamten had a higher effect than aficamten on gradient reduction; among the included BBs, metoprolol showed the highest gradient reduction, while among CCBs, verapamil was the most effective (inter-action P < 0.01). Similar results were observed for provocable LVOT gradients. CONCLUSION: Pharmacological therapies effectively reduced LVOT gradients in oHCM patients to varying degrees, with disopyramide and CMIs showing the highest effect, followed by BBs and CCBs.
Key Findings
1
Beta blockers (BBs) and calcium channel blockers (CCBs) showed moderate reductions in LVOT gradients, less than disopyramide and CMIs.
2
Disopyramide and cardiac myosin inhibitors (CMIs) produced the largest reductions in LVOT gradients among evaluated therapies.
3
Pharmacological therapies reduce left ventricular outflow tract (LVOT) gradients in patients with obstructive hypertrophic cardiomyopathy (oHCM).
4
The magnitude of LVOT gradient reduction varies across different pharmacological classes.
Research Object
Patients with obstructive hypertrophic cardiomyopathy (oHCM) experiencing left ventricular outflow tract (LVOT) obstruction
Research Subject
Efficacy of pharmacological therapies (disopyramide, cardiac myosin inhibitors, beta-blockers, calcium channel blockers) in reducing LVOT gradients/outflow tract obstruction
Publication Details
Publication Date
2025-05-16
Journal
Publisher
ISSN
Cited by
8
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement2009
Bias in meta-analysis detected by a simple, graphical test1997
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement2009
RoB 2: a revised tool for assessing risk of bias in randomised trials2019
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions2016
2023 ESC Guidelines for the management of cardiomyopathies2023